Your session is about to expire
← Back to Search
PET Imaging for Alzheimer's Disease
Study Summary
This trial is studying a brain inflammation marker in people with neurodegenerative disorders.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I do not have any untreated serious illnesses that would make joining unsafe.I haven't taken NSAIDs, aspirin, corticosteroids (except for skin), or immunosuppressants like methotrexate in the last month.I cannot travel to the NIH for treatment.I am allergic to ketoprofen or have had stomach or intestinal bleeding.I am HIV positive.I agree to follow the lifestyle guidelines provided.I am 18 years old or older.I do not have major diseases that could affect my thinking or memory.I understand the study and agree to sign the consent form.I am 18 years old or older.I agree to follow the lifestyle guidelines provided.I cannot lie flat or still for two hours due to issues like claustrophobia, weight, or uncontrollable behavior.I have never been treated with Aduhelm.I have been diagnosed with a neurodegenerative condition like Alzheimer's, Parkinson's, or Huntington's disease.I am in good health overall, as confirmed by my doctor.Your doctor needs to check the pulse in your wrist to make sure it's strong enough and make sure there are no metal or foreign objects in both wrists.I have been diagnosed with a brain condition like MCI, ALS, Parkinson's, or dementia by a specialist.I am 18 years old or older.
- Group 1: Only one arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current enrollment capacity for this clinical trial?
"Indeed, the information on clinicaltrials.gov implies that this medical study is looking to enroll volunteers. The trial was first posted on August 17th 2021 and has been updated most recently on September 29th 2022. Currently, 136 participants are sought from a single site for this endeavor."
Is it possible for me to register my participation in this clinical experiment?
"This research seeks 136 participants afflicted with dementia and aged 18-99. For inclusion in the study, individuals must: be male or female; possess an understanding of the trial that allows for written informed consent to be signed (or have their LAR do so); demonstrate good general health as evidenced by medical history and physical examination; show sufficient ulnar collateral flow on a radial artery pulse check; adhere to lifestyle considerations; not suffer from cognitive impairment, already enrolled in either 01-M-0254 or 17-M-0181 studies."
Has this therapeutic intervention been granted authorization by the Federal Drug Administration?
"Our team at Power has given this treatment a safety rating of 1, since it is currently in the Phase 1 trial phase and thus only possesses minimal data to support its efficacy."
Are there any prior research endeavors that have explored this avenue of treatment?
"Currently, there are 7 ongoing studies that analyze this pharmaceutical with 0 Phase 3 trials. While the majority of experiments for this drug happen in Philadelphia, Pennsylvania, 9 distinct sites are executing these investigations."
Is this venture a pioneering initiative?
"Currently, 7 ongoing trials are taking place in 3 cities across 2 nations regarding this particular treatment. Initially trialled by Bayer in 2010 on 161 subjects and having passed the drug-approval stage; a dozen studies have since been finished."
Could individuals aged 45 or younger be considered for participation in this medical experiment?
"Eligibility for this trial is limited to those 18-99 years old. Nonetheless, there are 123 studies available for minors and 1311 trials open to seniors."
Are there still vacancies for individuals to join this trial?
"Affirmative. The information hosted on clinicaltrials.gov confirms that this medical study, which was first advertised in August of 2021, is actively enrolling participants. 136 individuals are needed to join at 1 research centre."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger